Sign in
Enrolling by invitationNo phase

Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials

Key facts

Who runs it
Ramon Diaz-Arrastia
Where
Philadelphia, United StatesSee the site
Trial code
Status
Enrolling by invitation
People taking part
215 people, planned
Started
3 Sept 2026
Expected to end
31 Jul 2030
Type of study
Observational, 2 groups
Treatments tested
  • Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
Record updated
30 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age 18 years and older
  • Evidence of mechanical energy impacting the head or inertial forces affecting the head
  • Either (A) or (B):; Trauma-related abnormality on CT scan on admission; If CT normal, documented/verified TBI based on evidence of either loss of consciousness, post-traumatic amnesia, confusion, or post-traumatic symptoms
  • Age 18 years and older
  • No history of TBI in the past 12 months

Who cannot take part

  • Subjects with magnetic-sensitive devices implanted in their head or within 12 in. (30 cm) of the coil/probe (examples: cochlear implants, deep brain stimulators, vagus nerve stimulators, other implanted electrodes/stimulators, aneurysm clips or coils, stents and bullet fragments)
  • Subjects with magnetic-sensitive devices implanted in their head or within 12 in. (30 cm) of the coil/probe (examples: cochlear implants, deep brain stimulators, vagus nerve stimulators, other implanted electrodes/stimulators, aneurysm clips or coils, stents and bullet fragments)
  • History of disabling pre-existing neurologic disease (Such as epilepsy, brain tumors, meningitis, cerebral palsy, encephalitis, brain abscesses, vascular malformations, cerebrovascular disease, Alzheimer's disease, multiple sclerosis, or HIV-encephalitis)
  • History of premorbid disabling condition that interfere with outcome assessments
  • History of disabling pre-existing neurologic disease (Such as epilepsy, brain tumors, meningitis, cerebral palsy, encephalitis, brain abscesses, vascular malformations, cerebrovascular disease, Alzheimer's disease, multiple sclerosis, or HIV-encephalitis)
  • History of premorbid disabling condition that interfere with outcome assessments
  • Bilaterally absent pupillary responses
  • Penetrating traumatic brain injury
  • Prisoners or patients in police custody
  • Pregnancy
  • Prisoners or patients in police custody
  • Pregnancy

Where in United States

  • University of PennsylvaniaPhiladelphia, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).

The 2 groups in the trial

  • Traumatic Brain Injury (Acute, Subacute, Chronic)

    Treatment: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)

  • Healthy Control

    Treatment: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials (TMS-EEG)
Record updated
30 October 2026